Search

Your search keyword '"Shokouhi, Shervin"' showing total 221 results

Search Constraints

Start Over You searched for: Author "Shokouhi, Shervin" Remove constraint Author: "Shokouhi, Shervin"
221 results on '"Shokouhi, Shervin"'

Search Results

5. Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial

6. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial

13. Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial

16. Liposomal amphotericin for secondary prophylaxis: A systematic review and meta-analysis.

19. Mucormycosis, New Causative Agents, and New Susceptible Populations: Review of Cases in a Tertiary Care Hospital in Iran (2007-2021)

20. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial

27. Efficacy of Hemoperfusion in Severe and Critical Cases of COVID-19

30. Clinical Aspects, Microbiological Features, and Therapeutic Outcome of Brain Abscess: An Experience of a Referral Center

32. Efficacy of Hemoperfusion in Severe and Critical Cases of COVID-19.

33. Study of the effects of interferon β−1a on hospitalized patients with COVID‐19: SBMU Taskforce on the COVIFERON study

34. Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER)

40. Efficacy of Hemoperfusion in Severe and Critical Cases of COVID-19

42. Efficacy of Interferon β-1a in Treatment of Hospitalized COVID-19 Patients; SBMU Taskforce on the COVIFERON Study

44. Emergence of carbapenem resistant Acinetobacter baumannii clonal complexes CC2 and CC10 among fecal carriages in an educational hospital.

46. An Investigation Into the Beneficial Effects of High-Dose Interferon beta 1-a, Compared to Low-Dose Interferon Beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19

47. Role of Interferon Therapy in Severe COVID-19: The COVIFERON Randomized Controlled Trial

Catalog

Books, media, physical & digital resources